An ETF with stocks picked by artificial intelligence benefited from a meme stock-style explosion—something even a robot trader couldn't have predicted. Read More...
Motley Fool
Why BioNTech Is Tumbling Today
After a spike in price following the release of its latest earnings, BioNTech (NASDAQ: BNTX) fell below the waterline on Tuesday. In a combined earnings release and corporate update, BioNTech revealed that it earned just under 6.09 billion euros ($7.05 billion), a giant leap above the less than 68 million euros ($79 million) of the same quarter last year. The reason, it nearly goes without saying by now, is sales of the Comirnaty coronavirus vaccine it developed in partnership with U.S. pharmaceutical giant Pfizer.
Add Comment